Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Ceribell Inc (CBLL)

Ceribell Inc (CBLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference GlobeNewswire - Wed Apr 29, 3:05PM CDT

SUNNYVALE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.20 (-0.88%)
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026 GlobeNewswire - Mon Apr 20, 3:05PM CDT

SUNNYVALE, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.20 (-0.88%)
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results GlobeNewswire - Tue Feb 24, 3:05PM CST

SUNNYVALE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.20 (-0.88%)
Ceribell to Participate in Upcoming March Investor Conferences GlobeNewswire - Wed Feb 18, 3:05PM CST

SUNNYVALE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.20 (-0.88%)
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 GlobeNewswire - Tue Feb 10, 3:05PM CST

SUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.20 (-0.88%)
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution GlobeNewswire - Mon Jan 5, 7:00AM CST

SUNNYVALE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.20 (-0.88%)
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire - Tue Dec 30, 2025

SUNNYVALE, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.20 (-0.88%)
Medical Breakthroughs: 5 AI Innovators Redefining What's Possible BayStreet.ca - Thu Dec 18, 2025

Issued on behalf of VentriPoint Diagnostics Ltd. VANCOUVER – Baystreet.ca News Commentary – The healthcare AI market reached $21.66 billion in 2025 and analysts now project growth to $110.61...

CBLL : 20.20 (-0.88%)
ONMD : 1.0200 (+4.34%)
VPT.VN : 0.130 (-10.34%)
LNAI : 0.3300 (-0.90%)
ABSI : 5.90 (+2.61%)
VPTDF : 0.1010 (-5.25%)
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution GlobeNewswire - Tue Dec 9, 2025

SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.20 (-0.88%)
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates GlobeNewswire - Mon Nov 24, 2025

SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.20 (-0.88%)

Barchart Exclusives

Palantir Stock Has a ‘High-Class Problem’: Demand for Its Software Is Far Outpacing Supply Barchart - Sun May 10, 4:00PM CDT
Palantir’s greatest challenge may no longer be demand, but how quickly it can deliver AI software to customers. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.